Altech Chemicals Ltd (ASX:ATC) is aiming to become one of the world's leading producers of 99.99% (4N) high purity alumina (HPA) (Al2O3) through the construcon and operaon of a 4,500tpa HPA plant at Tanjung Langsat Industrial Complex, Johor, Malaysia. Feedstock for the HPA plant will be sourced from the Company’s 100%-owned kaolin deposit at Meckering, Western Australia. HPA is a high-value, high margin and highly demanded product as it is the crical ingredient required for the producon of synthec sapphire. Synthec sapphire is used in the manufacture of substrates for LEDs; semiconductor wafers used in the electronics industry; and scratch-resistant sapphire glass used for wristwatch faces, opcal windows and smartphone components. An emerging use for HPA is as a coang for lithium-ion baery separators. There is no substute for HPA in the manufacture of synthec sapphire. Altech is fast-tracking the development of its HPA project aſter securing a 10-year off-take agreement with Mitsubishi for 100% of its proposed HPA producon. To learn more, visit: www.altechchemicals.com De.mem Ltd (ASX:DEM) is a Singaporean-Australian decentralised water and waste-water treatment business that designs, builds, owns and operates water and waste water treatment systems for its clients. De.mem operates in the industrial segment providing systems and soluons to customers from the mining, electronics, chemicals, oil & gas and the food & beverage industries and in the municipal and residenal segments. De.mem has licensed proprietary technologies from its partner in research & development, Singapore’s Nanyang Technological University (NTU), including an exclusive worldwide license for a revoluonary low-pressure hollow fibre nanofiltraon membrane. Through its wholly owned water and waste water treatment original equipment manufacturing (OEM) subsidiary Akwa-Worx Pty Ltd, De.mem has a strong presence in Australia. Akwa-Worx has a market reputaon for building high quality Australian designed and manufactured products and has long-term customers in the Australian mining industry. To learn more, visit: www.demembranes.com DomaCom Ltd (ASX:DCL) provides and fraconal investment plaorm that allows financial advisers and investors to Crowdfund (aka Syndicate) the equity and the debt needed to purchase an investment property or to complete a property development on a rent-to-build basis. DomaCom has an AFSL and is licenced as a fund manager for the DomaCom Fund which has been added to the approved product list of over 40 IFA dealer groups – nearly 5% of the Australian financial adviser market. Our fee model is that DomaCom charges 0.88% MER on the Funds Under Management(FUM) and the company has just introduced an upfront fee of 2.76% for development projects. The recent Federal Court SMSF win along with the upcoming Senior Equity Release product should result in the next 12 months being a pivotal me for the company. To learn more, visit: www.domacom.com.au Hazer Group Ltd (ASX:HZR) was founded in 2010 to commercialise technology developed at the University of Western Australia, aſter which the Company listed on the ASX in December 2015. Prior to lisng, over eight (8) years was spent developing the underlying Hazer Process, using natural gas and unprocessed iron ore to create low cost, low-emission “clean” hydrogen, considered to be a key fuel in the transion to low carbon economy. In addion to the hydrogen product, the Hazer Process also produces synthec graphite, used in lithium ion baeries, lubricaon and industrial applicaons. In early 2016 Hazer developed a research partnership with the University of Sydney, and established core development operaons and is focussing on being the lowest cost hydrogen provider for the low carbon industrial hydrogen market and emerging hydrogen energy market. Together with this Hazer also wants to become a key player in the premium graphite sector. Since researched commenced in 2007 the Hazer technology has undergone numerous scale-up stages and is now in the late stages of the development journey, with focus now turning towards solidifying further commercializaon pathways, partnerships and oake agreements. The graphite aspects of the technology are being jointly developed in partnership with Mineral Resources Ltd (MRL). To learn more, visit: www.hazergroup.com.au BrainChip Holdings Ltd (ASX:BRN) is an ASX-listed, leading provider of neuromorphic compung soluons, a type of arficial intelligence that is inspired by the biology of the human neuron. The Company’s revoluonary new spiking neural network technology can learn autonomously, evolve and associate informaon just like the human brain. The proprietary technology is fast, completely digital and consumes very low power. The Company provides soſtware and hardware soluons that address the high-performance requirements in civil surveillance, gaming, financial technology, cybersecurity, ADAS, autonomous vehicles, and other advanced vision systems. The company provides the award winning BrainChip Studio and BrainChip Accelerator, and recently introduced the Akida Neuromorphic System-on-Chip. To learn more, visit: www.brainchipinc.com Emerge Gaming Ltd (ASX:EM1), founded in 2014, is a leading eSports and Casual gaming tournament company. Emerge Gaming operates the online eSports and casual gaming tournament plaorm and lifestyle hub “Arcade X”. Via this plaorm, casual, social and hardcore gamers can play more than 300 gaming tles against each other via their mobile, console or PC which allows users to engage in skill-based compeve gaming compeons in eSports, including peer-to-peer matches and tournaments. The plaorm uses its unique IP, advanced analycs tracking and proprietary algorithms to deliver an opmum tournament gaming experience for users while providing adversers with the perfect vehicle for delivery of their messaging to a fully engaged audience offering the opportunity to sponsor tournaments and compeons by branding the tournament or compeon pages, providing brands direct access to, and engagement with, e-Sports gamers. The Emerge Gaming Plaorm focuses on skill-based tournaments, matches, and AAA streaming where players compete to improve their user leaderboard rankings/status in the virtual gaming world and for digital merchandise to improve their gaming experience. In addion to this, the Plaorm offers a compeve marketplace which gives players the opportunity to enter ‘pay-to-play’ compeons and tournaments. To learn more, visit: www.emergegaming.com.au Family Zone Cyber Safety Ltd (ASX:FZO) is an ASX listed, global cyber safety provider. The Company has developed a world first cyber safety ecosystem which has been embraced by over 80,000 parents and more than 600 schools across Australia, New Zealand and the USA. The Company has also secured re-seller arrangements with some telecommunicaons operators servicing in excess of 1B subscribers. Global, scalable and doubling in revenue every 6 months, Family Zone is now taking off. To learn more, visit: www.familyzone.com/au Sydney, NSW Tuesday 30 October 2018 Radisson Blu Hotel Melbourne, VIC Thursday 1 November 2018 Grand Hya Hotel BeerCells is an online hub that connects Funconal and Integrated Medical Praconers with individuals looking to improve health and wellness, resolve health problems and/or prevent chronic illness. BeerCells enables people to test and manage their personal data securely online. This data can be shared with experts located anywhere in the world, who can review results and proficiently guide you to beer health soluons. Informave and assuring, BeerCells empowers individuals to take ownership of their own health, their own data to make improved informed lifestyle choices. To learn more, visit: www.beercells.com HeraMED Ltd - The pregnancy experience reinvented! HeraMED is a technology start-up developing innovave, connected, smart pregnancy monitoring soluons for home and professional use. Harnessing state-of-the-art technology with superior UX/UI, our innovaons are medically accurate, scienfically opmised, safe and affordable. Our technology-driven products change the way praconers and expectant mothers approach and monitor the miracle of pregnancy and have the potenal to impact the lives of millions of people. To learn more, visit: www.hera-med.com Vercal Events Pty Ltd Follow us on Instagram: instagram.com/vercalevents Suite 13-14, 186 Hay Street Subiaco WA 6008 PO Box 1153 Subiaco WA 6904 T: (61 8) 9388 2222 E: [email protected] W: www.vercalevents.com.au Follow us on Twier: @VEvents_RIU Mobilicom Ltd (ASX:MOB) is a high-tech company that designs, develops and markets soluons for mission crical and remote mobile private communicaon networks without the need for, or use of, any exisng infrastructure. Mobilicom’s products and technology are based on an innovave approach that merges 4G communicaon with Mobile MESH technologies into a unified soluon, with a number of product families that have been commercially deployed. Mobilicom develops in-house and fully owns all assets for its unique technology and soluons, including: 4G modem, MESH networking, radios, HW & SW applicaons, among others. The technology is backed by its patent holding and know-how. SkyHopper, the newest enty founded by Mobilicom Ltd. in 2016, targets the Professional, Commercial and Industrial UAV market, by leveraging Mobilicom’s core technology as well as its success in the Gov’t and Enterprise market. The SkyHopper family of products offers a wide range of soluons that have begun launching in April 2017. Despite the recent launch, SkyHopper PRO has already developed a track record with reference partners and customers on a global level. Furthermore, SkyHopper has gained an internaonal presence with its sales and markeng acvity and connues to build upon its excellent market tracon among industry leaders. To learn more, visit: www.mobilicom.com Memphasys Ltd (ASX:MEM) is a Sydney-based ASX-listed company that specialises in high value biological separaons. The Company’s core technology - electrophoresis combined with size exclusion proprietary membranes - has been proven as an efficient and cost effecve means of separang targeted cells from biological fluids. The major current applicaon is in separang sperm cells from human seminal plasma for ART (Assisted Reproducve Technology). Memphasys is also considering adding to this core ART product by expanding the scope to include animal-versions of the human ART product, and by licensing synergisc reproducve biology IP from the University of Newcastle. The first commercial applicaon of the core technology is the development of a device called Felix to separate sperm cells from human semen for use in ART in IVF clinics. This includes all forms of ART including tradional IVF ( in vitro ferlisaon), ICSI (intra cytoplasmic sperm injecon), and IUI (intra uterine inseron) and can be applied to humans and a range of animals. To learn more, visit: www.memphasys.com